Cargando…
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
BACKGROUND: Anti-programmed cell death 1 (PD-1)/programmed death-ligand 1 (PD-L1) monoclonal antibodies (mAbs) show remarkable clinical anti-tumour efficacy. However, rational combinations are needed to extend the clinical benefit to primary resistant tumours. The design of such combinations require...
Autores principales: | Zalba, Sara, Belsúe, Virginia, Topp, Brian, de Alwis, Dinesh, Alvarez, Maite, Trocóniz, Iñaki F., Berraondo, Pedro, Garrido, María J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007692/ https://www.ncbi.nlm.nih.gov/pubmed/33531689 http://dx.doi.org/10.1038/s41416-020-01239-z |
Ejemplares similares
-
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021) -
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021) -
Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021) -
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors
por: Sancho-Araiz, Aymara, et al.
Publicado: (2021) -
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
por: Burn, Olivia K., et al.
Publicado: (2020)